23 May 2018 in Blood Pressure
Purpose: Chronic inflammatory diseases are related with earlier onset of atherosclerosis. We hypothesized that inflammatory bowel disease patients with chronic, systemic inflammation have an increased arterial stiffness associated with the disease duration. Also, we wanted to compare arterial stiffness markers between inflammatory bowel disease and well-controlled hypertension patients. Materials and methods: A total of 89 inflammatory bowel disease patients (60 patients with Crohn’s disease and 29 patients with ulcerative colitis, age range 20–64 years) without history of arterial hypertension or diabetes were enrolled and age matched with a control group of patients (73 patients, age range 25–69 years, 41 (56.1%) males) with known history of well-controlled arterial hypertension. We have used a noninvasive device that simultaneously measures brachial blood pressure and estimates PWV and AIx in inflammatory bowel disease and hypertension groups of patients. Results: Patients with pathological PWV values were significantly older, had significantly longer duration of inflammatory bowel disease, higher values of serum cholesterol and HDL-cholesterol, and higher AIx (17.4% vs. 9.8%) (all p < .05). Higher PWV was associated with age and duration of inflammatory bowel disease in the linear regression model. PWV values were higher in hypertensive patients in the first two age quartiles while interestingly, in the last two quartiles, PWV was lower than in inflammatory bowel disease group of patients. Conclusions: Chronic subclinical inflammation is responsible for dyslipidemia and accelerated atherosclerosis which consequently alterates arterial elasticity. Inflammatory bowel disease and its duration should also be considered a risk factor for subclinical organ damage, as well as hypertension.
1 January 2020 in SSRN Electronic Journal
Introduction: An outbreak of coronavirus disease 19 (COVID-19) has altered the dynamic of world’s healthcare system, including endoscopic practices. Curious about the situation in different endoscopic units across the globe, the study was designed to evaluate different aspects of practice resumption worldwide. Methods: An online questionnaire was created and distributed by national/regional representatives. Redcap® platform was used as the interface; afterwards, Microsoft Excel 2016 and Prism 5 were utilized for data analysis. Results: A total of 307 responses from 47 countries/regions was collected, from which 290 valid answers were inducted and further analyzed. Almost half (47%) were in post-peak period by August, 2020. Many units were not designated to be COVID-oriented facility. About 15.5% of centers remained unrecovered, mainly in North and South America; those were recovered, training was still withheld significantly. Nevertheless, opened centers kept safety measurement strictly. Though patient load was decreased by 37% in most centers, waiting list was increased 0-25%. Among many surveillance methods, body temperature, PCR and chest CT prevailed the be the most commonly used. 74.8% claimed to have increased post-procedural disinfection time and 68.2% also observed an increased in per-case inspection. PPE usage was implemented highly and shortage of these posed as one of the resumption barriers. Post-procedural patient surveillance was not reinforced. Conclusions: The study reflected closely the global revolution of the pandemic. Shortage in staff and PPE as well as difficulty in training resumption remained barriers worldwide. Incapacity of patient post-procedural surveillance raised concerns in disease control. Funding Statement: None to declare. Declaration of Interests: None to declare. Ethics Approval Statement: The study was approved by the Institutional Review Board of the National Liver Institute, Menoufia University, Egypt (NLI IRB 00003413) in June 2020, protocol number 00203/2020.
1 September 2022 in Afro-Egyptian Journal of Infectious and Endemic Diseases
Background and study aim: During COVID-19 pandemic majority of non-emergency endoscopic procedures has been deferred. ERCP is required to address both elective as well as emergency causes such as biliary obstruction with cholangitis. Our aim to explore the status of ERCP in different endoscopy units from different countries and to report the characteristics of patients presented to these units and their procedure details. Patients and Methods: Representatives of main endoscopy units in different countries were invited to participate. Patient demographics, COVID-19 status, ERCP indications, laboratory findings, radiology findings, pre procedural preparation and post procedure complications were collected. Results: Data of 352 patients from 11 countries were collected. Average age of patients was 57.80 (SD ±16.88) years and 182 (51.7%) were females. Majority of patient 332 (94.3%) did not have COVID-19 infection. Most centers reported a decrease in procedure volume, staff number and duration of ERCP procedure during COVID-19. The most common indications for ERCP were choledocholithiasis (51.7%) and suspected malignant biliary stricture (30.1%). Deep biliary cannulation was achieved in 324 (92%) cases. The most common therapeutic interventions carried out were CBD stone extraction. Complications were observed in 20 (5.6%) cases with bleeding being the most common immediate complication that was reported in 4.3% of patients. Post ERCP pancreatitis (PEP) was reported in 2.8% of cases and it was managed conservatively. The most common final diagnoses were choledocholithiasis (57.4%) and benign biliary strictures (10.8%). Conclusion: COVID-19 pandemic negatively impacted ERCP procedure volume, training opportunities and was associated with decrease staff number and shorter procedure time.